Do you want to remove all your recent searches?

All recent searches will be deleted

Watch fullscreen

Biotech’s Bid For RNA Drugs

3 years ago|2 views
A new kind of vaccine may be on the horizon.
Biotech firm Moderna has created a flu vaccine that targets messenger RNA.
The goal is to coax cells to produce their own proteins to fight disease.
A recent test of the vaccine showed sufficient immune response to fight off the flu virus.
Moderna has attracted $1.9 billion in investor interest to continue their work.